Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer.

Genomics - 1 Nov 2020

Gao Lei, Meng Jialin, Zhang Yong, Gu Junfei, Han Zhenwei, Wang Xiaolu, Gao Shenglin

Abstract excerpt

The dysregulation of RNA binding proteins (RBPs) regulates the progression of several cancers. However, information on the overall functions of RBPs in prostate cancer (PCa) remains largely understudied. Therefore, based on the TCGA dataset, this study identified 144 differentially expressed RBPs in tumors compared to normal tissues. Subsequently, through univariate, LASSO and multivariate Cox regression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression

Share to Mutation

Share to Prognosis

Share to Prostatic Neoplasms

Share to RNA-Binding Proteins

Source

Identifiers

PMID: 32882325
DOI: 10.1016/j.ygeno.2020.08.034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer.PMID 32882325Read ↗

Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancerSemantic proximity Read ↗

Machine learning-based identification of co-expressed genes in prostate cancer and CRPC and construction of prognostic modelsSemantic proximity Read ↗

Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related GenesSemantic proximity Read ↗

Machine Learning-Based Identification of Co-expressed Genes in Prostate Cancer and CRPC and Construction of Prognostic ModelsSemantic proximity Read ↗

Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced StagesSemantic proximity Read ↗

Identification and validation of a ferroptosis-related genes based prognostic signature for prostate cancerSemantic proximity Read ↗

Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancerSemantic proximity Read ↗

Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.Semantic proximity Read ↗

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate CancerSemantic proximity Read ↗

Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate CancerSemantic proximity Read ↗

RNA modification Regulators' Co-Expression Score (RMRCoeS) predicts biochemical recurrence and therapy response in prostate cancer: A multi-omics and experimental validation study.Semantic proximity Read ↗

Constructing lactylation-related genes prognostic model to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on machine learningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.